Combination Effective as First-Line Therapy in Advanced ER-Positive HER2-Negative Breast Cancer
In this open label phase 2 BOLERO-4 study, researchers evaluated the effect of everolimus plus endocrine therapy on progression-free survival.
Diagnosis & Disease Information
Partial Response Reported With Abemaciclib for Breast Cancer Metastases to Brain
Researchers seeking to determine whether breast cancer metastases to the brain would respond to abemaciclib presented the results of a phase 2 Simon 2-stage trial at SABCS 2017.
Oncotype DX Recurrence Score a Potential Marker of Hereditary Breast Cancer
Researchers conducted a review of more than 400 patients with hormone receptor-positive breast cancer to determine if high Oncotype DX RS is associated with a greater likelihood the cancer is hereditary.
Letrozole Not Superior to Anastrazole for HR+, Node+ Early Breast Cancer
Letrozole was not superior to anastrazole with respect to efficacy or safety in postmenopausal women with HR-positive, node-positive early breast cancer.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...